Emmett, L., Sathekge, M., Crumbaker, M. A., Davis, C., Joshua, A. M., Mdlophane, A. H., Nguyen, A., Bruchertseifer, F., Ndlovu, H., Ratnayake, L., Sibiya, S. M., Rangwala, F. A., Schoenberger, M., Wehbe, J., Emineni, S., Xu, Z., Morgenstern, A. (2026). AcTION: Phase 1 study of [
                    <sup>225</sup>
                    Ac]Ac-PSMA-617 (
                    <sup>225</sup>
                    Ac-PSMA-617) in men with metastatic castration-resistant prostate cancer (mCRPC) with or without prior [
                    <sup>177</sup>
                    Lu]Lu-PSMA (
                    <sup>177</sup>
                    Lu-PSMA) radioligand therapy (RLT).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5010